Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 6.53 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.53 | 52 Week High | $ | |||
| Open | $6.53 | 52 Week Low | $ | |||
| Day High | $6.53 | P/E | N/A | |||
| Day Low | $6.53 | EPS | $ | |||
| Volume | 642 | |||||

